// App-Quantinova.ai

OC 54.2 : Validation of a Hospital-Acquired Venous Thrombosis Risk Assessment Model: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study

Researchers

Presenter

  • N. Zakai

Principal Investigators

  • K. Wilkinson

  • A. Sparks

  • I. Koh

  • R. Thomas

  • J. Schaefer

  • N. Smith

  • C. Holmes

  • M. Cushman

Medical Centers

  • University of Vermont, COLCHESTER, Vermont, United States

  • University of Vermont, Burlington, Vermont, United States

  • SyllogisTeks, Burlington, Vermont, United States

  • Hennepin Health Care Research Institute, HHS, Minneapolis, MN, United States,

  • University of Michigan Medical School, Ann Arbor, Michigan, United States

  • Department of Epidemiology, University of Washington; Department of Health Service, University of Washington; Seattle Epidemiologic Research and Information Center; Department of Veterans Affairs, Office of Research and Development, Seattle, WA 98105, USA, Seattle, Washington, United States

  • University of Vermont College of Medicine, Burlington, Vermont, United States

  • Centers for Disease Control and Prevention, Atlanta, GA

  • Larner College of Medicine at the University of Vermont, Colchester, Vermont, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • The National Institutes of Health and Centers for Disease Control and Prevention

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved